BBNX Beta Bionics, Inc.

$19.90 +2.50%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

Beta Bionics, Inc. (BBNX) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $895 million. Shares last traded at $19.90, 40.6% below their 52-week high. Over the past year the stock is up 1.1%. Net profit margin is -61.3%, below the peer median of -9.3%. Revenue grew 53.9% year over year.

Market Cap

$895M

Shares Out

45.0M

EPS (TTM)

$-4.26

P/E Ratio

—

P/S Ratio

7.52

P/B Ratio

3.49

Dividend / Share

—

Dividend Yield

—

52-Week High

$33.50

52-Week Low

$8.80

Volume

66,985

Avg Vol (3m)

59,738.413

Performance

+1.79%

+42.96%

+43.32%

+79.60%

YTD

-31.97%

+1.07%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

62.45

SMA (50)

$17.10

SMA (200)

$16.76

Price vs SMA50

+16.40%

Price vs SMA200

+18.74%

ATR (14)

$1.20

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$119M

Net Income

$-73M

Gross Margin

58.3%

Operating Margin

-69.8%

Net Margin

-61.3%

Return on Equity

-28.5%

Return on Assets

-25.0%

Current Ratio

8.88

Debt / Equity

0.14

Revenue Growth (YoY)

+53.9%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-1.02	2026-07-29
Q1 2026	$-0.49	2026-04-21
FY 2025	$-1.81	2026-02-24
Q3 2025	$-1.52	2025-10-28
Q2 2026	$-1.23	2026-07-29
Q1 2026	$-0.93	2026-04-21

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

BBNX vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/S vs peers

7.52 / 2.94 med

+156% premium

Net margin vs peers

-61.3% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.